235 related articles for article (PubMed ID: 18523430)
1. Oxalate in renal stone disease: the terminal metabolite that just won't go away.
Marengo SR; Romani AM
Nat Clin Pract Nephrol; 2008 Jul; 4(7):368-77. PubMed ID: 18523430
[TBL] [Abstract][Full Text] [Related]
2. Oxalate: from the environment to kidney stones.
Brzica H; Breljak D; Burckhardt BC; Burckhardt G; Sabolić I
Arh Hig Rada Toksikol; 2013 Dec; 64(4):609-30. PubMed ID: 24384768
[TBL] [Abstract][Full Text] [Related]
3. [Abnormalities in the erythrocyte membrane transport of oxalate in calcium oxalate lithogenesis].
Baggio B; Gambaro G; Marchini F; Cicerello E; Borsatti A
Nephrologie; 1984; 5(4):173-4. PubMed ID: 6527719
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of early time calcium oxalate nephrolithiasis.
Jordan WR; Finlayson B; Luxenberg M
Invest Urol; 1978 May; 15(6):465-8. PubMed ID: 649295
[TBL] [Abstract][Full Text] [Related]
5. Renal physiology of SLC26 anion exchangers.
Sindić A; Chang MH; Mount DB; Romero MF
Curr Opin Nephrol Hypertens; 2007 Sep; 16(5):484-90. PubMed ID: 17693766
[TBL] [Abstract][Full Text] [Related]
6. Absence of the sulfate transporter SAT-1 has no impact on oxalate handling by mouse intestine and does not cause hyperoxaluria or hyperoxalemia.
Whittamore JM; Stephens CE; Hatch M
Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G82-G94. PubMed ID: 30383413
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic calcium oxalate nephrolithiasis: a cellular disease.
Gambaro G; Baggio B
Scanning Microsc; 1992 Mar; 6(1):247-54. PubMed ID: 1626244
[TBL] [Abstract][Full Text] [Related]
8. Renal excretion of oxalate in patients with chronic renal failure or nephrolithiasis.
Chen SM; Chen TW; Lee YH; Chu WY; Young TK
J Formos Med Assoc; 1990 Aug; 89(8):651-6. PubMed ID: 1981225
[TBL] [Abstract][Full Text] [Related]
9. Oxalate transport and calcium oxalate renal stone disease.
Verkoelen CF; Romijn JC
Urol Res; 1996; 24(4):183-91. PubMed ID: 8873376
[TBL] [Abstract][Full Text] [Related]
10. Erythrocyte transmembrane flux and renal clearance of oxalate in idiopathic calcium nephrolithiasis.
Gambaro G; Petrarulo M; Nardelotto A; Marangella M; Baggio B
Kidney Int; 1995 Nov; 48(5):1549-52. PubMed ID: 8544412
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of oxalate cellular transport in idiopathic calcium nephrolithiasis.
Baggio B; Gambaro G
J Nephrol; 1998; 11 Suppl 1():63-5. PubMed ID: 9604815
[No Abstract] [Full Text] [Related]
12. Specific modulatory effect of arachidonic acid on human red blood cell oxalate transport: clinical implications in calcium oxalate nephrolithiasis.
Baggio B; Priante G; Brunati AM; Clari G; Bordin L
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S381-4. PubMed ID: 10541268
[TBL] [Abstract][Full Text] [Related]
13. Nephrocalcinosis: molecular insights into calcium precipitation within the kidney.
Sayer JA; Carr G; Simmons NL
Clin Sci (Lond); 2004 Jun; 106(6):549-61. PubMed ID: 15027893
[TBL] [Abstract][Full Text] [Related]
14. Dietary oxalate loads and renal oxalate handling.
Holmes RP; Ambrosius WT; Assimos DG
J Urol; 2005 Sep; 174(3):943-7; discussion 947. PubMed ID: 16094002
[TBL] [Abstract][Full Text] [Related]
15. Oxalate, calcium and ash intake and excretion balances in fat sand rats (Psammomys obesus) feeding on two different diets.
Palgi N; Vatnick I; Pinshow B
Comp Biochem Physiol A Mol Integr Physiol; 2005 May; 141(1):48-53. PubMed ID: 15922640
[TBL] [Abstract][Full Text] [Related]
16. Nephrolithiasis and nephrocalcinosis with calcium oxalate crystals in the kidneys and other organs; report of two cases.
LUND T; RESKE-NIELSEN E
Acta Pathol Microbiol Scand; 1956; 38(5):353-63. PubMed ID: 13339329
[No Abstract] [Full Text] [Related]
17. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
18. Primary hyperoxaluria: clinical course, diagnosis, and treatment after kidney failure.
Raju DL; Cantarovich M; Brisson ML; Tchervenkov J; Lipman ML
Am J Kidney Dis; 2008 Jan; 51(1):e1-5. PubMed ID: 18155525
[TBL] [Abstract][Full Text] [Related]
19. Evidence of a link between erythrocyte band 3 phosphorylation and anion transport in patients with 'idiopathic' calcium oxalate nephrolithiasis.
Baggio B; Bordin L; Gambaro G; Piccoli A; Marzaro G; Clari G
Miner Electrolyte Metab; 1993; 19(1):17-20. PubMed ID: 8393959
[TBL] [Abstract][Full Text] [Related]
20. SLC26A6 and NADC‑1: Future direction of nephrolithiasis and calculus‑related hypertension research (Review).
Yang X; Yao S; An J; Jin H; Wang H; Tuo B
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34458928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
